Monday - May 25, 2026
FDA Center for Biologics Evaluation & Research Issues Warning Letter to Estar Technologies
May 13, 2026
WASHINGTON, May 13 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Estar Technologies Ltd. from its Center for Biologics Evaluation and Research:

* * *

Recipient: Aaron Esteron, Chief Executive Officer and Founder, Estar Technologies Ltd, 15, Ha-Merkava, Holon 5885111, Israel, Aaron@estar-medical.com

Issuing Office: Center for Biologics Evaluation and Research, United States

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products